Literature DB >> 32246226

Impact of depressive symptoms on self-perceived severity of autonomic dysfunction in multiple system atrophy: relevance for patient-reported outcomes in clinical trials.

Jose Martinez1, Jose-Alberto Palma1, Lucy Norcliffe-Kaufmann1, Amir Garakani2,3, Horacio Kaufmann4.   

Abstract

PURPOSE: To assess the relationship between depressive symptoms and self-perceived severity of autonomic dysfunction in patients with multiple system atrophy (MSA).
METHODS: Cross-sectional evaluation of patients with MSA who underwent autonomic testing, Unified MSA Rating Scale (UMSARS)-1 and -2, rating of the presence and severity of depressive symptoms (Zung scale), quality of life (SF-36), body vigilance, anxiety (Spielberger's anxiety scale), severity of autonomic dysfunction with the Composite Autonomic Symptoms Score (COMPASS-31), and severity of orthostatic hypotension (OH) symptoms with the Orthostatic Hypotension Questionnaire (OHQ).
RESULTS: Fifty-eight patients (32 women) with probable MSA (aged 61.8 ± 8.6 years; disease duration 4.3 ± 2.1 years) were studied. Forty patients (69%) had symptoms of depression in the Zung scale. Age, disease duration, and motor disability were similar in those with and without symptoms of depression. Despite a similar orthostatic blood pressure fall, the severity of orthostatic symptoms was higher in patients with symptoms of depression (p = 0.004). Depression scores were associated with higher burden of autonomic symptoms (R = 0.401, p = 0.02), specifically with the COMPASS-31 items related to orthostatic intolerance (R = 0.337, p = 0.045), and with the OHQ (R = 0.529; p < 0.001). A multivariable regression model including age, sex, UMSARS, and drop in systolic blood pressure upon head-up tilt as covariates showed that the burden of depressive symptoms was independently associated with the OHQ score: for every 1-unit increase in the Zung depression score, there was a 1.181-point increase in the total OHQ score.
CONCLUSIONS: In patients with MSA, depressive symptoms worsen the perceived severity of autonomic symptoms in general and orthostatic hypotension in particular. Our findings have implications for clinical trial design.

Entities:  

Keywords:  Depression; Multiple system atrophy; Non-motor symptoms; Orthostatic hypotension; Symptomatic burden

Year:  2020        PMID: 32246226     DOI: 10.1007/s10286-020-00681-6

Source DB:  PubMed          Journal:  Clin Auton Res        ISSN: 0959-9851            Impact factor:   4.435


  4 in total

Review 1.  Symptomatic Care in Multiple System Atrophy: State of the Art.

Authors:  Anna Grossauer; Victoria Sidoroff; Beatrice Heim; Klaus Seppi
Journal:  Cerebellum       Date:  2022-05-17       Impact factor: 3.847

Review 2.  Multiple system atrophy.

Authors:  Werner Poewe; Iva Stankovic; Glenda Halliday; Wassilios G Meissner; Gregor K Wenning; Maria Teresa Pellecchia; Klaus Seppi; Jose-Alberto Palma; Horacio Kaufmann
Journal:  Nat Rev Dis Primers       Date:  2022-08-25       Impact factor: 65.038

Review 3.  Limitations of the Unified Multiple System Atrophy Rating Scale as outcome measure for clinical trials and a roadmap for improvement.

Authors:  Jose-Alberto Palma; Patricio Millar Vernetti; Miguel A Perez; Florian Krismer; Klaus Seppi; Alessandra Fanciulli; Wolfgang Singer; Phillip Low; Italo Biaggioni; Lucy Norcliffe-Kaufmann; Maria Teresa Pellecchia; Maria José Martí; Han-Joon Kim; Marcelo Merello; Iva Stankovic; Werner Poewe; Rebecca Betensky; Gregor Wenning; Horacio Kaufmann
Journal:  Clin Auton Res       Date:  2021-02-07       Impact factor: 4.435

4.  Altered voxel-level whole-brain functional connectivity in multiple system atrophy patients with depression symptoms.

Authors:  Hua Guang Yang; Weiyin Vivian Liu; Zhi Wen; Lan Hua Hu; Guo Guang Fan; Yun Fei Zha
Journal:  BMC Psychiatry       Date:  2022-04-20       Impact factor: 3.630

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.